Anti-TBCD monoclonal antibody

Pre-made anti-TBCD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TBCD/TBCD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1896-Ab-1/ GM-Tg-hg-IP1896-Ab-2Anti-Human TBCD monoclonal antibodyHuman
GM-Tg-rg-IP1896-Ab-1/ GM-Tg-rg-IP1896-Ab-2Anti-Rat TBCD monoclonal antibodyRat
GM-Tg-mg-IP1896-Ab-1/ GM-Tg-mg-IP1896-Ab-2Anti-Mouse TBCD monoclonal antibodyMouse
GM-Tg-cynog-IP1896-Ab-1/ GM-Tg-cynog-IP1896-Ab-2Anti-Cynomolgus/ Rhesus macaque TBCD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1896-Ab-1/ GM-Tg-felg-IP1896-Ab-2Anti-Feline TBCD monoclonal antibodyFeline
GM-Tg-cang-IP1896-Ab-1/ GM-Tg-cang-IP1896-Ab-2Anti-Canine TBCD monoclonal antibodyCanine
GM-Tg-bovg-IP1896-Ab-1/ GM-Tg-bovg-IP1896-Ab-2Anti-Bovine TBCD monoclonal antibodyBovine
GM-Tg-equg-IP1896-Ab-1/ GM-Tg-equg-IP1896-Ab-2Anti-Equine TBCD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1896-Ab-1/ GM-Tg-hg-IP1896-Ab-2; GM-Tg-rg-IP1896-Ab-1/ GM-Tg-rg-IP1896-Ab-2;
GM-Tg-mg-IP1896-Ab-1/ GM-Tg-mg-IP1896-Ab-2; GM-Tg-cynog-IP1896-Ab-1/ GM-Tg-cynog-IP1896-Ab-2;
GM-Tg-felg-IP1896-Ab-1/ GM-Tg-felg-IP1896-Ab-2; GM-Tg-cang-IP1896-Ab-1/ GM-Tg-cang-IP1896-Ab-2;
GM-Tg-bovg-IP1896-Ab-1/ GM-Tg-bovg-IP1896-Ab-2; GM-Tg-equg-IP1896-Ab-1/ GM-Tg-equg-IP1896-Ab-2
Products NameAnti-TBCD monoclonal antibody
Formatmab
Target NameTBCD
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TBCD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1896-Ag-1Recombinant multi-species TBCD/ PEBAT/ SSD-1 protein


    Target information

    Target IDGM-IP1896
    Target NameTBCD
    Gene ID6904,108903,100361417,719682,491683,101084074,281515,100056490
    Gene Symbol and Synonyms2310057L06Rik,A030005L14Rik,mKIAA0988,PEBAT,SSD-1,TBCD,tfcD
    Uniprot AccessionQ9BTW9,Q28205
    Uniprot Entry NameTBCD_HUMAN,TBCD_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000141556
    Target ClassificationN/A

    The target: TBCD, gene name: TBCD, also named as PEBAT, SSD-1, tfcD. Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.